让下一篇重要论文，不再错过。

原文摘要

Accurate segmentation of the mitral valve from three-dimensional transesophageal echocardiography (3D TEE) is severely restricted by the scarcity of publicly available expert- annotated volumetric datasets. To address this critical limitation, we investigated Fourier Domain Adaptation (FDA), utilizing general-purpose generative-AI images (from platforms like Chat- GPT, Google Gemini, and Microsoft MAI) as annotation-free style donors for 3D mitral valve segmentation. We employed a DeepMitral residual U-Net model on the public MVSeg2023 dataset, comparing six conditions over three runs: real-only training, traditional augmentation, FDA with each generative source, and a non-AI FDA control using real-image style donors, plus an optimization-matched real-only control and a \b{eta} sensitivity analysis. Case-level paired testing showed that FDA with these generative sources led to significant reductions in boundary- and surface-related errors across all three donor conditions relative to the primary real-only baseline. However, the impact on the core segmentation metric, Generalized Dice Score (GDS), proved generator-dependent. ChatGPT-FDA showed a significant GDS advantage over the optimization-matched control but not over the primary baseline, and Gemini-FDA showed no significant GDS difference. Notably, only MAI-FDA provided a statistically robust and significant increase in GDS compared to the primary baseline. The \b{eta} sensitivity was not robust across training runs. These findings confirm that FDA remains an important augmentation mechanism. While generative-AI images offer a practical means of acquiring style diversity without new annotations, the non-AI control performed comparably to ChatGPT-FDA, so we do not conclude that this approach is superior to training with real-image donors.